Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on: January 15,2024

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on:January 15,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on: July 02,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on:July 02,2024

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on: April 14,2024

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on:April 14,2024

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga

Updated on: May 27,2024

Team explores anti-breast cancer properties of soy

by University of ArizonaOrnella I. Selmin, PhD (left), and Donato F. Romagnolo, PhD (right). Credit: University of Arizona Cancer CenterA University of Arizona Cancer Center research team is enga

Updated on:May 27,2024

Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on: May 27,2024

Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on:May 27,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on: May 27,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on:May 27,2024

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on: February 01,2024

Study uncovers potential therapeutic approach for advanced prostate cancer

by Melissa Rohman,Northwestern UniversityPALI1 bridges the interaction between PRC2 (SUZ12/EZH2/EED) and G9A to catalyze dual H3K9 and H3K27 methylation, which leads to strong repression of GPS

Updated on:February 01,2024

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on: February 03,2024

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on:February 03,2024

New study uncovers key culprit behind pediatric brain cancer metastasis

byUniversity of Pittsburgha, A heatmap of gene expression in the four MB subgroups (G3, group 4 (G4), SHH and WNT) and in unaffected (normal) tissues. Twofold change; false discovery rate (FDR) 

Updated on: January 12,2024

New study uncovers key culprit behind pediatric brain cancer metastasis

byUniversity of Pittsburgha, A heatmap of gene expression in the four MB subgroups (G3, group 4 (G4), SHH and WNT) and in unaffected (normal) tissues. Twofold change; false discovery rate (FDR) 

Updated on:January 12,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on: November 10,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on:November 10,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on: February 20,2024

Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

by NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of melanoma recurring or causing death by 44% w

Updated on:February 20,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on: January 22,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on:January 22,2024